Lineage Cell Therapeutics Inc(LCTX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

LCTX Lineage Cell Therapeutics Inc

休市中 12-12 16:00:00 EST

1.66

-0.05

-2.92%

盘后1.69

+0.03+1.81%

19:45 EST

最高1.72	最低1.66	成交量80.30万
今开1.70	昨收1.71	日振幅3.51%
总市值3.82亿	流通市值2.95亿	总股本2.30亿
成交额135.44万	换手率0.45%	流通股本1.78亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"LCTX","market":"US","secType":"STK","nameCN":"Lineage Cell Therapeutics Inc","latestPrice":1.66,"timestamp":1765573200000,"preClose":1.71,"halted":0,"volume":802964,"hourTrading":{"tag":"盘后","latestPrice":1.69,"preClose":1.66,"latestTime":"19:45 EST","volume":27680,"amount":46071.9425,"timestamp":1765586751188},"delay":0,"floatShares":177829652,"shares":230327537,"eps":-0.29305,"marketStatus":"休市中","change":-0.05,"latestTime":"12-12 16:00:00 EST","open":1.7,"high":1.72,"low":1.66,"amount":1354385.47513,"amplitude":0.035088,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.29305,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1765789200000},"marketStatusCode":7,"adr":0,"listingDate":699771600000,"exchange":"AMEX","adjPreClose":1.71,"preHourTrading":{"tag":"盘前","latestPrice":1.7398,"preClose":1.71,"latestTime":"09:28 EST","volume":135,"amount":233.839008,"timestamp":1765549705516},"postHourTrading":{"tag":"盘后","latestPrice":1.69,"preClose":1.66,"latestTime":"19:45 EST","volume":27680,"amount":46071.9425,"timestamp":1765586751188},"volumeRatio":0.9066968266729776,"impliedVol":0.4111,"impliedVolPercentile":0.26},"requestUrl":"/m/hq/s/LCTX/wiki","defaultTab":"wiki","newsList":[{"id":"1171475599","title":"Lineage Cell Therapeutics第三季度净亏损2975.2万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1171475599","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1171475599?lang=zh_cn&edition=full","pubTime":"2025-11-20 01:01","pubTimestamp":1763571666,"startTime":"0","endTime":"0","summary":"11月6日 - Lineage Cell Therapeutics第三季度运营费用为746.7万美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LCTX"],"gpt_icon":0},{"id":"1154055064","title":"Lineage Cell Therapeutics Inc：以每股1.75美元的价格向Janus Henderson Investors出售1200万普通股","url":"https://stock-news.laohu8.com/highlight/detail?id=1154055064","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1154055064?lang=zh_cn&edition=full","pubTime":"2025-11-12 22:28","pubTimestamp":1762957695,"startTime":"0","endTime":"0","summary":"Lineage Cell Therapeutics Inc：以每股1.75美元的价格向Janus Henderson Investors出售1200万普通股","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LCTX"],"gpt_icon":0},{"id":"2577430291","title":"Lineage Cell Therapeutics, Inc.盘中异动 早盘股价大跌5.15%报1.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2577430291","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577430291?lang=zh_cn&edition=full","pubTime":"2025-10-22 22:25","pubTimestamp":1761143102,"startTime":"0","endTime":"0","summary":"北京时间2025年10月22日22时25分，Lineage Cell Therapeutics, Inc.股票出现异动，股价大幅跳水5.15%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.21%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251022222503a6c83615&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251022222503a6c83615&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","BK4539","LCTX","LENZ","LINE","BK4224"],"gpt_icon":0},{"id":"2569475758","title":"Lineage Cell Therapeutics, Inc.盘中异动 大幅拉升5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2569475758","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569475758?lang=zh_cn&edition=full","pubTime":"2025-09-23 01:16","pubTimestamp":1758561418,"startTime":"0","endTime":"0","summary":"北京时间2025年09月23日01时16分，Lineage Cell Therapeutics, Inc.股票出现异动，股价大幅拉升5.56%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.88%。其相关个股中，Qualigen Therapeutics, Inc.、Mbx Biosciences, Inc.、Metsera, Inc.涨幅较大，Qualigen Therapeutics, Inc.、Onconetix, Inc.、Mbx Biosciences, Inc.较为活跃，换手率分别为3187.70%、158.30%、67.32%，振幅较大的相关个股有Qualigen Therapeutics, Inc.、Mbx Biosciences, Inc.、Kodiak Sciences Inc，振幅分别为144.19%、86.84%、43.65%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250923011658a43cdab0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250923011658a43cdab0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LINE","BK4139","LENZ","BK4539","BK4224","LCTX","BK4007"],"gpt_icon":0},{"id":"2568226095","title":"Lineage Cell Therapeutics, Inc.盘中异动 股价大跌5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2568226095","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568226095?lang=zh_cn&edition=full","pubTime":"2025-09-19 21:59","pubTimestamp":1758290351,"startTime":"0","endTime":"0","summary":"北京时间2025年09月19日21时59分，Lineage Cell Therapeutics, Inc.股票出现波动，股价大幅下跌5.09%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.08%。其相关个股中，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Alx Oncology Holdings Inc.、Clearmind Medicine Inc.涨幅较大，Clearmind Medicine Inc.、Adaptimmune Therapeutics Plc、Aptevo Therapeutics Inc.较为活跃，换手率分别为579.31%、89.35%、76.17%，振幅较大的相关个股有Adaptimmune Therapeutics Plc、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Alx Oncology Holdings Inc.，振幅分别为25.75%、24.93%、20.18%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250919215911a72a6f0d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250919215911a72a6f0d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4224","LINE","LCTX","BK4007","BK4539","BK4139","LENZ"],"gpt_icon":0},{"id":"1107379737","title":"Lineage Cell Therapeutics Inc宣布与William Demant Invest合作开发用于听力损失治疗的Resonance™ (Anp1)","url":"https://stock-news.laohu8.com/highlight/detail?id=1107379737","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1107379737?lang=zh_cn&edition=full","pubTime":"2025-08-26 20:00","pubTimestamp":1756209620,"startTime":"0","endTime":"0","summary":"Lineage Cell Therapeutics Inc宣布与William Demant Invest达成研究合作协议，共同开发用于治疗听力损失的Resonance™ (Anp1)产品。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LCTX","BK4139"],"gpt_icon":0},{"id":"2558665056","title":"Lineage Cell Therapeutics, Inc.盘中异动 股价大涨6.66%报1.050美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558665056","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558665056?lang=zh_cn&edition=full","pubTime":"2025-08-11 21:44","pubTimestamp":1754919856,"startTime":"0","endTime":"0","summary":"北京时间2025年08月11日21时44分，Lineage Cell Therapeutics, Inc.股票出现异动，股价急速拉升6.66%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.23%。其相关个股中，Entero Therapeutics Inc.、Equillium, Inc.、Bioxcel Therapeutics, Inc.涨幅较大，Entero Therapeutics Inc.、Equillium, Inc.、Io Biotech, Inc.较为活跃，换手率分别为2598.16%、259.43%、82.15%，振幅较大的相关个股有Entero Therapeutics Inc.、Equillium, Inc.、Io Biotech, Inc.，振幅分别为74.27%、69.75%、20.72%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508112144169740e8bb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508112144169740e8bb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4224","LINE","BK4539","BK4139","LCTX","LENZ","BK4007"],"gpt_icon":0},{"id":"2557301828","title":"Lineage Cell Therapeutics, Inc.盘中异动 快速上涨5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557301828","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557301828?lang=zh_cn&edition=full","pubTime":"2025-08-07 02:16","pubTimestamp":1754504164,"startTime":"0","endTime":"0","summary":"北京时间2025年08月07日02时16分，Lineage Cell Therapeutics, Inc.股票出现波动，股价快速上涨5.26%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.15%。其相关个股中，Biomx Inc.、Protagenic Therapeutics Inc C/Wts 26/04/2026 、Rigel Pharmaceuticals, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Biomx Inc.、Tnf Pharmaceuticals, Inc.较为活跃，换手率分别为723.43%、604.52%、101.55%，振幅较大的相关个股有Briacell Therapeutics Corp C/Wts 26/02/2026、Biomx Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为57.18%、51.84%、48.52%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508070216049737ef84&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508070216049737ef84&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LCTX","LENZ","BK4139","BK4539","BK4007","LINE","BK4224"],"gpt_icon":0},{"id":"2556453228","title":"Lineage Cell Therapeutics, Inc.盘中异动 临近收盘急速跳水5.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2556453228","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556453228?lang=zh_cn&edition=full","pubTime":"2025-08-02 03:53","pubTimestamp":1754077998,"startTime":"0","endTime":"0","summary":"北京时间2025年08月02日03时53分，Lineage Cell Therapeutics, Inc.股票出现波动，股价急速下跌5.25%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.77%。其相关个股中，Equillium, Inc.、4D Molecular Therapeutics, Inc.、Sensei Biotherapeutics, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Equillium, Inc.、Tnf Pharmaceuticals, Inc.较为活跃，换手率分别为1785.52%、384.54%、308.60%，振幅较大的相关个股有Equillium, Inc.、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、天境生物，振幅分别为253.15%、72.18%、59.20%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250802035318a470429f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250802035318a470429f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4224","LINE","LCTX","BK4139","BK4007","BK4539"],"gpt_icon":0},{"id":"2555099029","title":"Lineage Cell Therapeutics, Inc.盘中异动 临近收盘快速跳水6.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555099029","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555099029?lang=zh_cn&edition=full","pubTime":"2025-07-31 03:40","pubTimestamp":1753904441,"startTime":"0","endTime":"0","summary":"北京时间2025年07月31日03时40分，Lineage Cell Therapeutics, Inc.股票出现异动，股价急速跳水6.07%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.15%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731034041a6ca25e7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731034041a6ca25e7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LINE","BK4007","LENZ","LCTX","BK4139","BK4224","BK4539"],"gpt_icon":0},{"id":"2554341770","title":"Lineage Cell Therapeutics, Inc.盘中异动 股价大涨5.31%报1.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2554341770","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554341770?lang=zh_cn&edition=full","pubTime":"2025-07-28 22:19","pubTimestamp":1753712380,"startTime":"0","endTime":"0","summary":"北京时间2025年07月28日22时19分，Lineage Cell Therapeutics, Inc.股票出现异动，股价急速拉升5.31%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.20%。其相关个股中，Celcuity Inc.、Aim Immunotech Inc.、Abpro Holdings Inc C/Wts 12/11/2029 涨幅较大，Aim Immunotech Inc.、Tnf Pharmaceuticals, Inc.、Cervomed Inc.较为活跃，换手率分别为313.11%、160.72%、109.68%，振幅较大的相关个股有Aim Immunotech Inc.、Celcuity Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 ，振幅分别为102.74%、75.82%、71.61%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072822194097235e56&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072822194097235e56&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4224","BK4139","LCTX","LINE","BK4007","BK4539","LENZ"],"gpt_icon":0},{"id":"2551947061","title":"Lineage Cell Therapeutics, Inc.盘中异动 临近收盘急速下跌5.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551947061","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551947061?lang=zh_cn&edition=full","pubTime":"2025-07-16 03:43","pubTimestamp":1752608634,"startTime":"0","endTime":"0","summary":"北京时间2025年07月16日03时43分，Lineage Cell Therapeutics, Inc.股票出现异动，股价快速下挫5.51%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.12%。其相关个股中，Cyclacel Pharmaceuticals, Inc.、Kairos Pharma, Ltd.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 涨幅较大，Cyclacel Pharmaceuticals, Inc.、Polyrizon Ltd.、60 Degrees Pharmaceuticals, Inc.较为活跃，换手率分别为3810.84%、2220.11%、1568.97%，振幅较大的相关个股有Cyclacel Pharmaceuticals, Inc.、Kairos Pharma, Ltd.、Polyrizon Ltd.，振幅分别为444.11%、116.77%、75.50%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716034354a44cf94f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716034354a44cf94f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4224","LINE","LCTX","BK4007","BK4539","BK4139","LENZ"],"gpt_icon":0},{"id":"2551844311","title":"Lineage Cell Therapeutics, Inc.盘中异动 股价大涨5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551844311","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551844311?lang=zh_cn&edition=full","pubTime":"2025-07-14 21:49","pubTimestamp":1752500979,"startTime":"0","endTime":"0","summary":"北京时间2025年07月14日21时49分，Lineage Cell Therapeutics, Inc.股票出现异动，股价快速上涨5.34%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.28%。其相关个股中，Sonnet Biotherapeutics Holdings, Inc.、Promis Neurosciences Inc.、Dare Bioscience, Inc.涨幅较大，Windtree Therapeutics, Inc.、Sonnet Biotherapeutics Holdings, Inc.、Dare Bioscience, Inc.较为活跃，换手率分别为1731.80%、593.92%、459.18%，振幅较大的相关个股有Promis Neurosciences Inc.、Dare Bioscience, Inc.、Biomx Inc.，振幅分别为163.93%、100.99%、87.78%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071421493997a5c14f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071421493997a5c14f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LINE","BK4224","BK4139","LENZ","LCTX","BK4539","BK4007"],"gpt_icon":0},{"id":"2550620982","title":"Lineage Cell Therapeutics, Inc.盘中异动 下午盘大幅跳水5.19%报1.01美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550620982","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550620982?lang=zh_cn&edition=full","pubTime":"2025-07-11 01:18","pubTimestamp":1752167930,"startTime":"0","endTime":"0","summary":"北京时间2025年07月11日01时18分，Lineage Cell Therapeutics, Inc.股票出现异动，股价大幅下挫5.19%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.46%。其相关个股中，Pelthos Therapeutics Inc.、Q32 Bio Inc.、Calidi Biotherapeutics, Inc.涨幅较大，Cognition Therapeutics, Inc.、Q32 Bio Inc.、Calidi Biotherapeutics, Inc.较为活跃，换手率分别为376.94%、345.08%、309.59%，振幅较大的相关个股有Seastar Medical Holding Corp C/Wts 28/10/2027 、Q32 Bio Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 ，振幅分别为91.19%、90.07%、74.89%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711011850a6a208c9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711011850a6a208c9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4224","BK4139","LENZ","LINE","BK4007","LCTX","BK4539"],"gpt_icon":0},{"id":"2550656898","title":"Lineage Cell Therapeutics, Inc.盘中异动 早盘大幅上涨5.51%报1.039美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550656898","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550656898?lang=zh_cn&edition=full","pubTime":"2025-07-09 22:12","pubTimestamp":1752070374,"startTime":"0","endTime":"0","summary":"北京时间2025年07月09日22时12分，Lineage Cell Therapeutics, Inc.股票出现波动，股价快速上涨5.51%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.31%。其相关个股中，Calidi Biotherapeutics, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Prokidney Corp.涨幅较大，Calidi Biotherapeutics, Inc.、Kazia Therapeutics Limited、Mustang Bio, Inc.较为活跃，换手率分别为830.79%、672.72%、495.57%，振幅较大的相关个股有Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Calidi Biotherapeutics, Inc.、Prokidney Corp.，振幅分别为112.02%、104.48%、48.79%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709221254953c3e7a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709221254953c3e7a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LINE","BK4224","LCTX","LENZ","BK4539","BK4139","BK4007"],"gpt_icon":0},{"id":"2549551344","title":"Lineage Cell Therapeutics, Inc.盘中异动 急速下挫5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2549551344","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549551344?lang=zh_cn&edition=full","pubTime":"2025-07-08 00:34","pubTimestamp":1751906079,"startTime":"0","endTime":"0","summary":"北京时间2025年07月08日00时34分，Lineage Cell Therapeutics, Inc.股票出现异动，股价大幅跳水5.20%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.61%。其相关个股中，Mustang Bio, Inc.、Pelthos Therapeutics Inc.、Artelo Biosciences, Inc.涨幅较大，Mustang Bio, Inc.、Artelo Biosciences, Inc.、Sonnet Biotherapeutics Holdings, Inc.较为活跃，换手率分别为5696.87%、1202.68%、877.56%，振幅较大的相关个股有Mustang Bio, Inc.、Pelthos Therapeutics Inc.、Artelo Biosciences, Inc.，振幅分别为298.32%、233.18%、84.08%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708003439a69b5586&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708003439a69b5586&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LCTX","BK4224","LINE","BK4007","LENZ","BK4539"],"gpt_icon":0},{"id":"2548818490","title":"Lineage Cell Therapeutics, Inc.盘中异动 大幅上涨5.18%报0.944美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548818490","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548818490?lang=zh_cn&edition=full","pubTime":"2025-07-02 22:06","pubTimestamp":1751465187,"startTime":"0","endTime":"0","summary":"北京时间2025年07月02日22时06分，Lineage Cell Therapeutics, Inc.股票出现波动，股价大幅上涨5.18%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.82%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702220627a72acbbe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702220627a72acbbe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LINE","BK4139","BK4007","BK4224","LCTX","BK4539","LENZ"],"gpt_icon":0},{"id":"2546245245","title":"Lineage Cell Therapeutics, Inc.盘中异动 早盘急速跳水5.09%报1.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546245245","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546245245?lang=zh_cn&edition=full","pubTime":"2025-06-25 21:42","pubTimestamp":1750858954,"startTime":"0","endTime":"0","summary":"北京时间2025年06月25日21时42分，Lineage Cell Therapeutics, Inc.股票出现波动，股价急速下挫5.09%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.48%。其相关个股中，Immatics N V C/Wts 01/07/2025 、Plus Therapeutics, Inc.、Nutriband Inc C/Wts 涨幅较大，Plus Therapeutics, Inc.、Zyversa Therapeutics, Inc.、Portage Biotech Inc.较为活跃，换手率分别为703.36%、200.61%、144.80%，振幅较大的相关个股有Immatics N V C/Wts 01/07/2025 、Plus Therapeutics, Inc.、内克塔治疗，振幅分别为135.80%、45.19%、26.05%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625214234952b3d3f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625214234952b3d3f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","LCTX","BK4224","BK4539","BK4007","LINE"],"gpt_icon":0},{"id":"2545123824","title":"Lineage Cell Therapeutics, Inc.盘中异动 早盘大幅上涨5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2545123824","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545123824?lang=zh_cn&edition=full","pubTime":"2025-06-24 21:33","pubTimestamp":1750772020,"startTime":"0","endTime":"0","summary":"北京时间2025年06月24日21时33分，Lineage Cell Therapeutics, Inc.股票出现异动，股价急速拉升5.22%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.52%。其相关个股中，内克塔治疗、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Ibio, Inc.涨幅较大，Adial Pharmaceuticals, Inc、Ibio, Inc.、Plus Therapeutics, Inc.较为活跃，换手率分别为496.10%、285.88%、217.62%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Xenetic Biosciences, Inc.、Vor Biopharma Inc.，振幅分别为33.79%、18.98%、17.52%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624213340978ce948&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624213340978ce948&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LINE","BK4007","LENZ","LCTX","BK4139","BK4224","BK4539"],"gpt_icon":0},{"id":"2545417835","title":"Lineage Cell Therapeutics, Inc.盘中异动 股价大涨5.02%报0.998美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545417835","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545417835?lang=zh_cn&edition=full","pubTime":"2025-06-23 21:30","pubTimestamp":1750685426,"startTime":"0","endTime":"0","summary":"北京时间2025年06月23日21时30分，Lineage Cell Therapeutics, Inc.股票出现异动，股价急速拉升5.02%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Impact Biomedical, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Cormedix Inc.涨幅较大，Indaptus Therapeutics, Inc.、Impact Biomedical, Inc.、Nucana Plc较为活跃，换手率分别为884.34%、866.08%、192.75%，振幅较大的相关个股有Impact Biomedical, Inc.、Nucana Plc、Abpro Holdings, Inc，振幅分别为5.50%、4.10%、3.59%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623213026a4b922a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623213026a4b922a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","LCTX","BK4224","BK4539","BK4007","LINE"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.lineagecell.com","stockEarnings":[{"period":"1week","weight":-0.0349},{"period":"1month","weight":-0.1399},{"period":"3month","weight":0.2388},{"period":"6month","weight":1.0481},{"period":"1year","weight":2.1923},{"period":"ytd","weight":2.3035}],"compareEarnings":[{"period":"1week","weight":-0.0057},{"period":"1month","weight":-0.0024},{"period":"3month","weight":0.037},{"period":"6month","weight":0.142},{"period":"1year","weight":0.1281},{"period":"ytd","weight":0.1633}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Lineage Cell Therapeutics, Inc.于1990年在加利福尼亚州成立。该公司是一家临床阶段的生物技术公司，开发新型同种异体或“现成的”细胞疗法，以满足未满足的医疗需求。公司项目基于公司专有的基于细胞的技术平台以及相关的开发和制造能力。从这个平台，该公司设计、开发、制造和测试具有与人体自然发现的细胞相似或相同的解剖和生理功能的专门人体细胞。","yearOnYearQuotes":[{"month":1,"riseRate":0.588235,"avgChangeRate":0.076795},{"month":2,"riseRate":0.277778,"avgChangeRate":-0.038556},{"month":3,"riseRate":0.666667,"avgChangeRate":0.057706},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.066398},{"month":5,"riseRate":0.444444,"avgChangeRate":-0.024474},{"month":6,"riseRate":0.444444,"avgChangeRate":0.029828},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.023648},{"month":8,"riseRate":0.352941,"avgChangeRate":-0.032113},{"month":9,"riseRate":0.529412,"avgChangeRate":0.024409},{"month":10,"riseRate":0.444444,"avgChangeRate":0.628473},{"month":11,"riseRate":0.388889,"avgChangeRate":-0.002727},{"month":12,"riseRate":0.555556,"avgChangeRate":0.016447}],"exchange":"AMEX","name":"Lineage Cell Therapeutics Inc","nameEN":"Lineage Cell Therapeutics Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Lineage Cell Therapeutics Inc(LCTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Lineage Cell Therapeutics Inc(LCTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Lineage Cell Therapeutics Inc,LCTX,Lineage Cell Therapeutics Inc股票,Lineage Cell Therapeutics Inc股票老虎,Lineage Cell Therapeutics Inc股票老虎国际,Lineage Cell Therapeutics Inc行情,Lineage Cell Therapeutics Inc股票行情,Lineage Cell Therapeutics Inc股价,Lineage Cell Therapeutics Inc股市,Lineage Cell Therapeutics Inc股票价格,Lineage Cell Therapeutics Inc股票交易,Lineage Cell Therapeutics Inc股票购买,Lineage Cell Therapeutics Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Lineage Cell Therapeutics Inc(LCTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Lineage Cell Therapeutics Inc(LCTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}